The table below shows CATALYST PHARMACEUTICALS, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
-
$119.07M
Cost of revenue
$87.25M
$68.84M
$51.97M
$34.39M
$21.88M
$17.04M
Gross profit
-
-
-
-
-
-
R&D
$12.71M
$12.65M
$93.15M
$19.79M
$16.94M
$16.50M
SG&A
CPRX annual revenue (10-K history)
CATALYST PHARMACEUTICALS, INC. reported annual revenue of $588.99M for fiscal year 2025. That is up 19.8% from $491.73M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
